RaySearch Laboratories AB (publ) (LON:0GRZ)

London flag London · Delayed Price · Currency is GBP · Price in SEK
243.77
-21.48 (-8.10%)
At close: Feb 21, 2025
176.70%
Market Cap 610.25M
Revenue (ttm) 86.03M
Net Income (ttm) 14.69M
Shares Out n/a
EPS (ttm) 0.43
PE Ratio 41.55
Forward PE n/a
Dividend 0.15 (0.06%)
Ex-Dividend Date n/a
Volume 57,300
Average Volume 6,884
Open 271.25
Previous Close 265.25
Day's Range 237.50 - 271.50
52-Week Range 6.15 - 15.70
Beta 1.32
RSI 47.91
Earnings Date Feb 21, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment ... [Read more]

Industry Prepackaged Software
Founded 1988
Employees 389
Stock Exchange London Stock Exchange
Ticker Symbol 0GRZ
Full Company Profile

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.